Form 483

ARx, LLC Form 483, 2022-06-03

FDA issued a Form 483 to ARx, LLC on 2022-06-03 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

ARx, LLC · Glen Rock, United States · Issued June 3, 2022

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

3 Jun 2022
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Yvins Dezan, Ankur C Patel, Jessica S Estriplet

3 Jun 2022
21 CFR 211.188(b)(11)

Identification of persons involved, each significant step

Cited by Yvins Dezan, Ankur C Patel, Jessica S Estriplet

3 Jun 2022
21 CFR 211.192

Extent of discrepancy, failure investigations

Cited by Yvins Dezan, Ankur C Patel, Jessica S Estriplet

3 Jun 2022
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Yvins Dezan, Ankur C Patel, Jessica S Estriplet

3 Jun 2022
21 CFR 211.46(b)

Equipment for Environmental Control

Cited by Yvins Dezan, Ankur C Patel, Jessica S Estriplet

Inspected site

ALARx, LLCGlen Rock, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)(11)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.46(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere